Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Director/PDMR Shareholding

15 Jul 2009 13:56

RNS Number : 7210V
Alexander Mining PLC
15 July 2009
 



Alexander Mining plc

("Alexander", the "Company")

15 July 2009

Employees', directors' and consultants' share options

In the best interests of Alexander and its shareholders, the Board has a policy of incentivising and retaining its employees, directors and technical consultants appropriately. This is especially important given that the Company's core intellectual property and 'know-how' is integral to the commercialisation of its proprietary mineral processing technology. In recognition, in a recent review, the Remuneration Committee has advised the Board that the existing share options do not best serve their intended purpose because the average weighted exercise price of 21.7p is some 3.8 times higher than the recent 20 day average closing mid-market share price of 5.68p.

In order to address this, the Board has approved that it offers those holding certain share options the opportunity to exchange their existing share options for the same number of new share options with a lower exercise price. In addition, it has also approved the issuance of new share options.

Further to the Board's decision, the following changes have been made:

A total of 4,358,333 share options issued to employees and directors with exercise prices ranging from 17.25p per share to 30p per share have been cancelled. An equal number of new share options have been issued in their place, with an exercise price of 10p per share, representing a 78% premium to the closing mid market share price on 14 July 2009, but otherwise subject to the same terms and conditions as the original share options.

An additional 1,816,667 share options have been granted to employees, directors and the Company's technical consultant. All such options have a ten year total life, an exercise price of 10p per share, with one third vesting every twelve months over a three year period from date of grant.

Details of the share options granted to the directors and the changes resulting from this reorganisation are as follows:

Director

Options surrendered July 2009 

Original exercise price

pence/share

Replacement options issued July 2009

New ptions

issued

July 2009

Total number of options July 2009

Matt Sutcliffe

(Executive Chairman)

1,000,000

30p

1,000,000

150,000

1,150,000

Martin Rosser

(Chief Executive Officer)

750,000

500,000

30p

17.25p

1,250,000

150,000

2,400,000

Roger Davey

(Non-executive Director)

250,000

30p

250,000

150,000

650,000

Jim Bunyan

(Non-executive Director)

250,000

30p

250,000

150,000

650,000

Emil Morfett

(Non-executive Director)

250,000

20.5p

250,000

150,000

650,000

All options in issue following the re-organisation have an exercise price of 10p per share.

In addition, the vesting conditions attached to the share options issued to the Company's technical consultant, Dr Nicholas Welham, have been reviewed to reflect the changing priorities of the research and development work he is undertaking on behalf of the Company.

Significant enhancements have been made by Dr Welham which will impact the future commercial applications of the AmmLeach® technology. However, this benefit to the Company has not resulted in the options issued to Dr Welham vesting under the existing terms and conditions. The Board has decided that, due to the evolving nature of the research activities, vesting conditions based on continuing service are more appropriate for the options issued to Dr Welham to ensure that he is rewarded for pursuing the most commercially beneficial research activities on behalf of the Company. Accordingly, the existing terms and conditions attaching to the options, notified to the market on 13 June 2008, have been replaced by service time based vesting conditions such that: 500,000 options will vest on the date of this announcement, a further 500,000 options will vest on 12 June 2010 and 500,000 options will vest on 12 June 2011.

Finally, 2.75m share options with an exercise price of 30p per share which were awarded to consultants now no longer involved with the Company will lapse within 30 days of this announcement.

As a result of the above changes, the Company will have a total of 10,775,000 options outstanding at an exercise price of 10p per share, representing 8.0% of the existing share capital of the Company. This compares with 12,208,333 options (9.1%) prior to the changes made.

For further information please contact:

Martin Rosser Matt Sutcliffe

Chief Executive Officer Executive Chairman

Mobile: + 44 (0) 7770 865 341 Mobile: +44 (0) 7887 930 758

Alexander Mining plc

1st Floor

35 Piccadilly

London

W1J 0DW

Tel: +44 (0) 20 7292 1300

Fax: +44 (0) 20 7292 1313

Email: mail@alexandermining.com

Website: www.alexandermining.com

Nominated Adviser and Broker

Alasdair Younie/John Prior

Arbuthnot Securities Limited

Arbuthnot House

20 Ropemaker Street

London, EC2Y 9AR

Tel: +44 (0) 20 7012 2000

Public/Media Relations

Tim Blackstone

Britton Financial PR

43 Lambs Conduit Street

London

EC1N 3NG

Tel: +44 (0) 20 7242 9786

Mobile: +44 (0) 7957 140 416

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDGDRSUBGGCU
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.